Blood glucose monitoring

Reach, Prof. G., Bobigny, France Why do patients hesitate to perform SMBG and how to overcome the barriers?

Owens, Dr. D., Llandough Hospital, Penarth, United Kingdom Current debate on the clinical utility of SMBG in patients with T2D not using insulin and learnings

Schnell, Prof. O., Munich, Germany Hypoglycemia: The neglected complication?

Hanefeld, Prof. M., Dresden, Germany HbA1c for diagnosis of diabetes: What are we gaining, what are we loosing?

Bergenstal, Prof. R., Minneapolis, United States Multitasking: The Path to Effective Diabetes Self-Management

Bergenstal, Prof. R., Minneapolis, United States The Role of SMBG in Diabetes Management – from Measurement to Therapeutic Action

Jovanovic, Dr. L., Santa Barbara, United States Optimized Diabetes Therapy – Limiting Glycemic Fluctuations

Garg, Prof. S., Aurora, United States Improving Diabetes Management with Decision Support Tools

Christiansen, Prof. J. S., Aarhus, Denmark What is Normal Glucose? – Continuous Glucose Monitoring Data from Healthy Subjects

Heinemann, Prof. L., Neuss, Germany Concepts to Close the Loop: Will it Become Reality?

Klonoff, Prof. D. C., San Mateo, United States Overview of the technology and research of continuous glucose monitors

Block, BS, RN J., Stanford, United States Prospective vs retrospective CGM – clinical application and utility

McGarraugh, Prof. G., Alameda, United States FreeStyle navigator™ Real time continuous glucose monitoring

Pfeiffer, Prof. A. F. H., Berlin, Germany Summary and outlook towards the future of glucose monitoring

Danne, Prof. T., Hannover, Germany Continuous glucose monitoring (CGM): the third pillar of glucose management after BGM and HbA1c

Bugler, Prof. J., Alameda, United States FreeStyle Navigator™ design and technology overview

Clarke, Prof. W., Charlottesville, United States New perspectives on evaluating continuous glucose monitors for clinical accuracy

Feldman, Dr. B., Alameda, United States FreeStyle Navigator Design and Technology Overview

Bode, Prof. B. W., Atlanta, United States Review of home use clinical trial: Clinical application of an interstitial fluid glucose monitor

Clarke, Prof. W., Charlottesville, United States New perspectives on evaluating continuous monitors for clinical accuracy

Kovatchev, Prof. B., Charlottesville, United States Overview of the continuous glucose-error grid analysis (CG-EGA): Advancements and application using Freestyle Navigator data

Feldman, Prof. J., Jerusalem, Israel Dielectrical impedance spectroscopy of biological systems

Caduff, Dr. A., Zurich, Switzerland Impedance spectroscopy based glucose monitoring

Flacke, Dr. F., Zurich, Switzerland Practical aspects of using the Pendra® device

Forst, Prof. T., Mainz, Germany Overview of controlled clinical study results

Pfützner, Prof. A., Mainz, Germany Performance of Pendra® during special situations in diabetes mellitus

Colagiuri, Dr. S., Sydney, Australia Type 2 diabetes – Current guidelines and recommendations

Kolb, Prof. H., Dusseldorf / Neuss, Germany Studies about SMBG – Real world versus clinical trials

Martin, Prof. S., Dusseldorf, Germany There is more to glucose monitoring than just HbA1c

Bergenstal, Prof. R., Minneapolis, United States Is SMBG a "must"? – Behavioral change in type 2 diabetes

Wenzel, MAS H., Germany Does SMBG save Money? – Body of current knowledge

Massi-Benedetti, Prof. M., Perugia, Italy The Challenge of Diabetes Management – Normalising Blood Glucose

Bergenstal, Prof. R., Minneapolis, United States Diabetes Management – Today’s Standards

Scherbaum, Prof. W. A., Dusseldorf, Germany The Value of SMBG for Diabetes Management – Current Evidence

Garg, Prof. S., Aurora, United States First data from ACCU-CHEK Advisor Insulin Guidance Software

Jansen, Dr. J., Amsterdam, Netherlands Meta-analysis of clinical trials

Karter, Prof. A., Oakland, United States Effectiveness of SMBG: Findings from a large US Health Care Provider, Kaiser Permanente

Kolb, Prof. H., Dusseldorf / Neuss, Germany What is the appropriate study design: randomised controlled or observational?

Heller, Prof. S., University of Sheffield, Sheffield, United Kingdom Clinical view: what does this mean for our patients?

Martin, Prof. S., Dusseldorf, Germany The ROSSO-Trial: Reality of blood glucose monitoring in Germany

Bergenstal, Prof. R., Minneapolis, United States Blood Glucose Monitoring as an Integral Part of Diabetes Management